Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
117032-51-6
1262770-54-6
139549-71-6
30364-60-4
65869-63-8
55750-63-5
142374-19-4 | N-Boc-4-piperidineacetaldehyde | AA003UH3 | MFCD03425258
429-06-1 | Tetraethylammonium tetrafluoroborate | AA003ULD | MFCD00011827
56388-66-0 | 1,3-Dithiole, 2-(1,3-dithiol-2-ylidene)-, homopolymer | AA01X3B0 | MFCD00005492
4206-58-0 | (E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)acrylaldehyde | AA003UUF | MFCD00075980
6056-50-4 | Tricyclohexyltin hydride | AA003UYA | MFCD03701502
1066-45-1 | Trimethyltin chloride | AA003V1Z | MFCD00000520
42910-16-7 | Triundecylamine | AA003V6D | MFCD10000964
14634-93-6 | Zinc N-Ethyl-N-phenyldithiocarbamate | AA003VBB | MFCD00059686
997-95-5 | N-Nitrosodiisobutylamine | AA003W1R | MFCD00210333
891638-31-6 | [(1-Morpholin-4-ylcycloheptyl)methyl]amine | AA003X6E | MFCD05201533